Other Information
−Removed: the quarter ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”
+Added: the quarter ended June 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”
or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).
16 unchanged sentences
(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on September 13, 2023)
+Added: Certificate of Amendment to Amended and Restated Certificate of Incorporation of InspireMD, Inc.
+Added: (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on June 3, 2026)
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
13 unchanged sentences
the undersigned thereunto duly authorized.
+Added: August 14, 2026
Marvin Slosman
1 unchanged sentence
Executive Officer)
+Added: August 14, 2026
Michael Lawless
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.